Pluristem Therapeutics Inc (PSTI)

[FDApproved]

Pluri Report Out !!!

Pluri is at the forefront of this extraordinary new world.

Our state-of-the-art, proprietary bioreactor system – developed over many years during our work in regenerative medicine –
provides a 3D micro-environment for cells, resembling their natural environment.
Our advanced manufacturing technology is tightly controlled, completely automated, efficient and scalable. It can generate
high-quality cell products on a mass scale with batch-to-batch consistency, whether these cells derive from humans, plants or
animals. Our cell expansion platforms are emerging as the new gold standard to accelerate creation of cell-based solutions.

https://pluri-biotech.com/wp-content/uploads/2023/09/Pluri-Report-2023-final.pdf